AAV-GAD gene therapy

glutamic acid decarboxylase gene therapy · Neurologix, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV-GAD gene therapy, covering 2008-03-27 to 2008-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease [Phase 1]